ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
SABCS 2022
ecancer
SABCS 2022 Genomic Assay and Prediction of Long-Term Prognosis in Premenopausal Patients With Early HR+ BC
FEATURING
Ruth O'Regan
- 175 views
- January 10, 2023
- 1
ecancer
SABCS 2022 Breast Cancer Patients and Interrupted ET to Pursue Pregnancy: Updates on Short-Term Recurrence Rates
FEATURING
Cristina Saura
- 96 views
- January 10, 2023
- 1
ecancer
SABCS 2022 EMERALD Phase 3 Trial: Elacestrant and PFS in ER+/HER2- mBC
FEATURING
Virginia Kaklamani
- 2,421 views
- January 10, 2023
- 15
ecancer
SABCS 2022 Primary Results From the POSITIVE Trial: Interruption of ET in Young BC Patients and the Risk of Short-Term Relapse
FEATURING
Ann H. Partridge
- 592 views
- January 10, 2023
- 4
ecancer
SABCS 2022 Follow-Up of Patients With Early BC After 30 Years: Radiotherapy and Survival Improvement
FEATURING
Ian Kunkler
- 94 views
- January 10, 2023
- 2
ecancer
SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patients With HER2+ Unresectable/mBC Previously Treated With T-DM1
FEATURING
Ian Krop
- 99 views
- January 10, 2023
ecancer
SABCS 2022 Treatment Decision Guided by CTC Count and Long-Term Outcomes for mBC
FEATURING
Jean-Yves Pierga
- 288 views
- January 10, 2023
- 1
ecancer
SABCS 2022 Updates From TAILORx and RxPONDER Trials: Implications for Practice
FEATURING
Christos Markopoulos,
Kevin Kalinsky
- 774 views
- January 10, 2023
- 6